metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Possible roles of Golgi protein-73 in liver diseases
Journal Information

Statistics

Follow this link to access the full text of the article

Concise review
Possible roles of Golgi protein-73 in liver diseases
Meng-Yuan Liua,b,d,1, Lu Huanga,b,d,1, Jiang-Feng Wua,b,d, Hong-Bing Zhange, Wen-Bing Aic,
Corresponding author
1043642574@qq.com

Corresponding authors.
, Rui-Tao Zhanga,b,d,
Corresponding author
zhangruitao@ctgu.edu.can

Corresponding authors.
a Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, China
b Medical College, China Three Gorges University, Yichang, China
c The Yiling Hospital of Yichang, 31 Donghu Road, Yi Ling District, Yichang 443100, Hubei, China
d Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China
e Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Read
1930
Times
was read the article
306
Total PDF
1624
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 June 58 10 68
2024 May 67 14 81
2024 April 84 20 104
2024 March 96 10 106
2024 February 324 2 326
2024 January 70 16 86
2023 December 55 12 67
2023 November 107 12 119
2023 October 122 31 153
2023 September 88 5 93
2023 August 43 6 49
2023 July 56 5 61
2023 June 40 4 44
2023 May 82 16 98
2023 April 36 1 37
2023 March 39 5 44
2023 February 47 9 56
2023 January 22 17 39
2022 December 18 6 24
2022 November 28 6 34
2022 October 32 28 60
2022 September 69 31 100
2022 August 13 15 28
2022 July 10 2 12
2022 June 9 13 22
2022 May 9 10 19
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos